DOI: https://doi.org/10.30978/CEES-2019-4-111

Радіоактивний йод проти раку щитоподібної залози

S. I. Rybakov

Анотація


-

Ключові слова


-

Повний текст:

PDF (Русский)

Посилання


Hertz S, Roberts A. Application of radioactive iodine in treatment in therapy of Graves’ disease. J Clin Investigation. 1942;21(1):31-32.

Hertz S, Roberts A. Radioactive iodine in the study of thyroid physiology VII. The use of radioactive iodine therapy in hyperthyroidism. JAMA. 1946;131:81-86.

Becker D, Sawin C. Radioiodine and Thyroid Disease: The Beginning Semin. Nucl Med. 1996;28, N 3:155-164.

Hertz B. A tribute to Dr. Saul Hertz:The discovery of the medical uses of radioiodine. World J Nucl Med. 2019;18(1):8-12.

Hamilton J, Soley M, Eichorn K. Deposition of radioactive iodine in human thyroid tissue. University California Publ. Pharmacol. 1940;1(28):339-367.

Hamilton J. The use of radioactive tracers in biology and medicine. Radiology. 1942;39:541-572.

Hertz S. A plan for analysis of the biologic factors involved in experimental carcinogenesis of the thyroid by means of radioactive isotopes. Bull New Engl Med Center. 1946;8:220-224.

Hertz S. Modifying effect of steroid hormone therapy on human neoplastic disease as judged by radioactive phosphorus (P-32) studies. J Clin Investigation. 1950;29:821.

Hertz S, Rooney J. Metabolic alterations in radioactive isotope concentration by malignant tissues induced by hormone pretreatment. Fed Proc. 1950;9:334-338.

Hertz B Dr. Saul Hertz (1905-1950) Discovers the Medical Uses of Radioactive iodine. The First Targeted Cancer Therapy. In:Thyroid Cancer. Advances in Diagnosis and Therapy H. Ahmadzadehfar (ed). Rijeca Croatia, 2016:1-14.

Keston A, Ball R, Franz V et al. Storage of radioactive iodine in metastasis from thyroid carcinoma. Science. 1942;95;362-363.

Frantz V, Ball R, Keston A et al. Thyroid carcinoma with metastases studied with radioactive iodine. Ann. Surgery. 1944;119:668-689.

Rawson R, Skanse B, Marinelli M et al. Radioactive iodine. Its use in studing certain function of normal and neoplastic thyroid tissue. Cancer. 1949;2(2):279-292.

Leiter L, Seidlin S, Marinelli L et al. Adenocarcinoma of the thyroid with the hyperthyroidism and functional metastases:1. Studies with thiouracil and radioiodine. J Clin Endocr Metab. 1946;6:247-261.

Benua R. Classics in Oncology:Introduction to «Radioactive Iodine Therapy: Effect on Functioning Metastases of Adenocarcinoma of the Thyroid» by Seidlin, Marinelli and Oshry. Cancer J for Clinicians. 1990;49(5):297-298.

Siegel E. The beginnings of radioiodine therapy of metastatic thyroid carcinoma:a memoir of Samuel Seidlin MD (1895-1995). Cancer Biother. Radiopharm. 1999;4(2):71-79.

Seidlin S, Marinelli M, Oshry B. Radioactive Iodine Therapy Effect on Functioning Metastases of Adenocarcinoma of the Thyroid. JAMA. 1946;132(14):838-847.

Seidlin S. Clinical methods and results of radioiodine therapy in metastatic thyroid cancer. Brookhaven Conference Report. 1948. DNL-C5:106-112.

Seidlin S, Rossman J, Oshry E. Radioiodine therapy of metastases from carcinoma of the thyroid. A six-year progress report. J Clin Endocrinol Metab. 1949; 9(11):1122-1137.

Seidlin S. Radioiodine in treatment metastatic thyroid carcinoma. Symposium on endocrine and metabolic disorders. Med Clin North Am. 1952;3(36):683-680.

Leiter L, Seidlin S, Marinelli L et al. The effect of thiouracil on hyperthyroidism and on the uptake of radioactive iodine in patients with adenocarcinoma of the thyroid and functioning metastases. J Clin Investigation. 1944;23:944-948.

Seidlin S, Oshry E, Yalow A. Spontaneous and experimentally induced uptake of radioactive iodine in metastases from thyroid carcinoma:a preliminary report. J Clin Endocrinol. 1948;8:423-432.

Seidlin S, Yalow A, Siegel E. Irradiation produced rise in blood radioiodine concentration following ingested therapeutic dose for metastatic thyroid carcinoma. Proc Soc Exp Biol Med. 1951;76:711-714.

Seidlin S, Yalow A, Siegel E. Blood radiation dose during radioiodine therapy of metastatic thyroid carcinoma. Radiology. 1954;63:797-813.

Seidlin S, Siegel E, Yalow A et al. Acute myeloid leukemia following prolonged iodine-131 therapy for metastatic thyroid carcinoma. Science. 1955:123:800-801.

Smithers D. Some varied applications of radioactive isotopes for the localisation and treatment of tumors. Acta Radiol. 1951;35(1):49-61.

Smithers D, Howard N, Trott N. Treatment of carcinoma of the thyroid with radioiodine. Br Med J. 1965; 2(5468):969-974.

Coliez R, Tubiana M, Sung S. Dissappearence of pulmo­nary metastases of thyroid cancer under the action of the radioactive iodine-131. J Radiol Electrol Arch Electr Med. 1951;32:396-399.

Tubiana M, Perez R, Parmentier C et al. The survival of patients with thyroid cancers treated with radioactive iodine. Apropos of 147 cases followed up more than 5 years. Presse. Med. 1968;761:999-2002.

Fahey F, Grant F, Thrall J. Saul Hertz MD and the birth of radionuclide therapy. Eur J Nucl Med Med Im Phys. 2017;4(1):15 doi 10.1186/s40658-017-01822-7/

Robbins D, Schlumberger M. The evolving role of ¹³¹I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 2015;46(1):28S-37S.

Goldsmith S. Radioactive iodine therapy of differentia­ted thyroid carcinoma:redressing the paradigm. Mol Im Radionucl Therapy. 2017. 1(1):74-79.

Nagarajah J, Janssen M, Hetkamp F et al. Iodine symporter targeting with I-124/131 theranostic. J Nucl Med. 2017;58(2):34S-38S.

Silberstein E. Radioiodine the classic theranostic agent. Semin Nucl Med. 2012;42(3):164-170.

Verburg F, Heinzel A, Hanscheid H et al. Nothing new under the nuclear sun:towards 80 years of theranostics in nuclear medicine. Eur J Nucl Med Mol Im. 2014; 41(2):199-201.

Yordanova A, Eppard E, Kurpig S et al. Theranostics in nuclear medicine practice. Onco Targets. Ther. 2017; 10:4821-4828.

Jadvar H, Chen X, Cai W et al. Radiotheranostics in cancer diagnosis and management. Radiology. 2018; 286(2):388-400.

Herrman K, Larson S, Weber W. Theranostic concepts:more than just a fashion trend-introduction. J Nucl Med. 2017;58(2):15-29.


Пристатейна бібліографія ГОСТ








Creative Commons License
Ця робота ліцензована Creative Commons Attribution 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter